| 1 |
Cancer-related inflammation
Alberto Mantovani, Paola Allavena, Antonio Sica et al. · Nature
Open access |
Jul 2008 |
11,477 |
| 2 |
Molecular mechanisms of cell death: recommendations of the Nomenclature Committee on Cell Death 2018
Lorenzo Galluzzi et al. · Cell Death and Differentiation
Open access169 authors |
23 Jan 2018 |
6,760 |
| 3 |
Macrophage plasticity and polarization: in vivo veritas
Antonio Sica, Alberto Mantovani · Journal of Clinical Investigation
Open access |
Mar 2012 |
6,482 |
| 4 |
Baseline Characteristics and Outcomes of 1591 Patients Infected With SARS-CoV-2 Admitted to ICUs of the Lombardy Region, Italy
Giacomo Grasselli et al. · JAMA
Open access114 authors |
6 Apr 2020 |
5,912 |
| 5 |
Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021
Laura Evans et al. · Intensive Care Medicine
Open access |
2 Oct 2021 |
5,314 |
| 6 |
Chronic inflammation in the etiology of disease across the life span
David Furman, Judith Campisi, Eric M. Verdin et al. · Nature Medicine
Open access |
Dec 2019 |
4,935 |
| 7 |
Tumour-associated macrophages as treatment targets in oncology
Alberto Mantovani, Federica Marchesi, Alberto Malesci et al. · Nature Reviews Clinical Oncology
ReviewOpen access |
24 Jan 2017 |
4,183 |
| 8 |
FDG PET/CT: EANM procedure guidelines for tumour imaging: version 2.0
Ronald Boellaard et al. · European Journal of Nuclear Medicine and Molecular Imaging
Open access |
Dec 2014 |
3,406 |
| 9 |
Neutrophils in the activation and regulation of innate and adaptive immunity
Alberto Mantovani, Marco Antonio Cassatella, Claudio Costantini et al. · Nature reviews. Immunology
ReviewOpen access |
25 Jul 2011 |
3,072 |
| 10 |
Cancer-related inflammation, the seventh hallmark of cancer: links to genetic instability
Francesco Colotta, Paola Allavena, Antonio Sica et al. · Carcinogenesis
|
25 May 2009 |
2,919 |
| 11 |
STRIDE-II: An Update on the Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE) Initiative of the International Organization for the Study of IBD (IOIBD): Determining Therapeutic Goals for Treat-to-Target strategies in IBD
Dan Turner, Amanda Ricciuto, Ayanna E. Lewis et al. · Gastroenterology
Open access |
20 Feb 2021 |
2,882 |
| 12 |
Recommendations for myeloid-derived suppressor cell nomenclature and characterization standards
Vincenzo Bronte, Sven Brandau, Shu‐Hsia Chen et al. · Nature Communications
Open access |
6 Jul 2016 |
2,806 |
| 13 |
2017 HRS/EHRA/ECAS/APHRS/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation
Hugh G Calkins et al. · Heart Rhythm
Open access |
12 May 2017 |
2,780 |
| 14 |
Macrophage plasticity and polarization in tissue repair and remodelling
Alberto Mantovani, Subhra Kumar Biswas, Maria Rosaria Galdiero et al. · The Journal of Pathology
|
24 Oct 2012 |
2,422 |
| 15 |
Sepsis and septic shock
Maurizio Cecconi, Laura Evans, Mitchell M. Levy et al. · The Lancet
|
21 Jun 2018 |
2,297 |
| 16 |
Diversity, Mechanisms, and Significance of Macrophage Plasticity
Massimo Locati, Graziella Curtale, Alberto Mantovani · Annual Review of Pathology Mechanisms of Disease
ReviewOpen access |
17 Sep 2019 |
2,266 |
| 17 |
Surviving Sepsis Campaign: guidelines on the management of critically ill adults with Coronavirus Disease 2019 (COVID-19)
Waleed A. Alhazzani et al. · Intensive Care Medicine
Open access |
28 Mar 2020 |
2,204 |
| 18 |
The gut-liver axis in liver disease: Pathophysiological basis for therapy
Agustı́n Albillos, Andrea De Gottardi, María Rescigno · Journal of Hepatology
Open access |
14 Oct 2019 |
2,173 |
| 19 |
Critical Care Utilization for the COVID-19 Outbreak in Lombardy, Italy
Giacomo Grasselli, Antonio Pesenti, Maurizio Cecconi · JAMA
Open access |
13 Mar 2020 |
2,164 |
| 20 |
Venous and arterial thromboembolic complications in COVID-19 patients admitted to an academic hospital in Milan, Italy
Corrado Lodigiani, G. Iapichino, Luca Carenzo et al. · Thrombosis Research
Open access |
23 Apr 2020 |
2,152 |
| 21 |
International validation of the consensus Immunoscore for the classification of colon cancer: a prognostic and accuracy study
Franck Pagès et al. · The Lancet
|
May 2018 |
2,133 |
| 22 |
3rd European Evidence-based Consensus on the Diagnosis and Management of Crohn’s Disease 2016: Part 1: Diagnosis and Medical Management
Fernando Gomollón et al. · Journal of Crohn s and Colitis
Open access |
22 Sep 2016 |
2,100 |
| 23 |
Modeling NAFLD disease burden in China, France, Germany, Italy, Japan, Spain, United Kingdom, and United States for the period 2016–2030
Chris Estes et al. · Journal of Hepatology
Open access |
7 Jun 2018 |
2,054 |
| 24 |
Microglia states and nomenclature: A field at its crossroads
Rosa Chiara Paolicelli et al. · Neuron
Open access |
Nov 2022 |
2,047 |
| 25 |
Allergic Rhinitis and its Impact on Asthma (ARIA) guidelines—2016 revision
Jan Brożek et al. · Journal of Allergy and Clinical Immunology
Open access |
8 Jun 2017 |
2,043 |
| 26 |
The Interleukin-1 Family: Back to the Future
Cecília Garlanda, Charles Anthony Dinarello, Alberto Mantovani · Immunity
Open access |
Dec 2013 |
1,970 |
| 27 |
ECCO-ESGAR Guideline for Diagnostic Assessment in IBD Part 1: Initial diagnosis, monitoring of known IBD, detection of complications
Christian Maaser et al. · Journal of Crohn s and Colitis
Open access |
17 Aug 2018 |
1,868 |
| 28 |
Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE): Determining Therapeutic Goals for Treat-to-Target
Laurent Peyrin‐Biroulet et al. · The American Journal of Gastroenterology
Open access |
25 Aug 2015 |
1,861 |
| 29 |
Macrophages as tools and targets in cancer therapy
Alberto Mantovani, Paola Allavena, Federica Marchesi et al. · Nature Reviews Drug Discovery
ReviewOpen access |
16 Aug 2022 |
1,842 |
| 30 |
Tofacitinib as Induction and Maintenance Therapy for Ulcerative Colitis
William J. Sandborn, Chinyu G. Su, Bruce E. Sands et al. · New England Journal of Medicine
Open access |
3 May 2017 |
1,772 |
| 31 |
Risk Factors Associated With Mortality Among Patients With COVID-19 in Intensive Care Units in Lombardy, Italy
Giacomo Grasselli et al. · JAMA Internal Medicine
Open access149 authors |
15 Jul 2020 |
1,747 |
| 32 |
Ulcerative colitis
Taku Kobayashi, Britta Siegmund, Catherine Le Berre et al. · Nature Reviews Disease Primers
Review |
10 Sep 2020 |
1,672 |
| 33 |
Defining ‘T cell exhaustion’
Christian U. Blank, W. Nicholas Haining, Werner Held et al. · Nature reviews. Immunology
ReviewOpen access |
30 Sep 2019 |
1,669 |
| 34 |
Efficacy and safety of dupilumab in patients with severe chronic rhinosinusitis with nasal polyps (LIBERTY NP SINUS-24 and LIBERTY NP SINUS-52): results from two multicentre, randomised, double-blind, placebo-controlled, parallel-group phase 3 trials
Claus Bachert et al. · The Lancet
|
19 Sep 2019 |
1,564 |
| 35 |
Tremelimumab plus Durvalumab in Unresectable Hepatocellular Carcinoma
Ghassan K. Abou‐Alfa et al. · NEJM Evidence
Open access |
6 Jun 2022 |
1,534 |
| 36 |
Macrophages, innate immunity and cancer: balance, tolerance, and diversity
Alberto Mantovani, Antonio Sica · Current Opinion in Immunology
Review |
10 Feb 2010 |
1,502 |
| 37 |
The EAACI/GA²LEN/EDF/WAO guideline for the definition, classification, diagnosis and management of urticaria
Torsten Zuberbier et al. · Allergy
Open access |
16 Jan 2018 |
1,456 |
| 38 |
Tumor-associated macrophages (TAM) as major players of the cancer-related inflammation
Graziella Solinas, Giovanni Germano, Alberto Mantovani et al. · Journal of Leukocyte Biology
Open access |
9 Sep 2009 |
1,443 |
| 39 |
Cholangiocarcinoma: current knowledge and future perspectives consensus statement from the European Network for the Study of Cholangiocarcinoma (ENS-CCA)
Jesús M. Bañales et al. · Nature Reviews Gastroenterology & Hepatology
ReviewOpen access |
20 Apr 2016 |
1,429 |
| 40 |
Targeting Tumor-Associated Macrophages with Anti-CSF-1R Antibody Reveals a Strategy for Cancer Therapy
Carola Hermine Ries et al. · Cancer Cell
Open access |
Jun 2014 |
1,404 |
| 41 |
ECCO Guidelines on Therapeutics in Crohn's Disease: Medical Treatment
Joana Torres et al. · Journal of Crohn s and Colitis
Open access |
2 Nov 2019 |
1,378 |
| 42 |
Neutrophil diversity and plasticity in tumour progression and therapy
Sébastien Jaillon, Andrea Ponzetta, Diletta Di Mitri et al. · Nature reviews. Cancer
Review |
21 Jul 2020 |
1,371 |
| 43 |
Towards the introduction of the ‘Immunoscore’ in the classification of malignant tumours
Jérôme Galon et al. · The Journal of Pathology
Open access |
11 Oct 2013 |
1,370 |
| 44 |
Radial versus femoral access in patients with acute coronary syndromes undergoing invasive management: a randomised multicentre trial
Marco Valgimigli et al. · The Lancet
Open access |
18 Mar 2015 |
1,311 |
| 45 |
NASH limits anti-tumour surveillance in immunotherapy-treated HCC
Dominik Reinhard Pfister et al. · Nature
Open access110 authors |
24 Mar 2021 |
1,304 |
| 46 |
Everolimus for the treatment of advanced, non-functional neuroendocrine tumours of the lung or gastrointestinal tract (RADIANT-4): a randomised, placebo-controlled, phase 3 study
James C. Yao et al. · The Lancet
Open access |
17 Dec 2015 |
1,288 |
| 47 |
Macrophage Polarization Comes of Age
Alberto Mantovani, Antonio Sica, Massimo Locati · Immunity
Open access |
Oct 2005 |
1,274 |
| 48 |
Efficacy and Safety of Nivolumab Plus Ipilimumab in Patients With Advanced Hepatocellular Carcinoma Previously Treated With Sorafenib
Thomas C. C. Yau et al. · JAMA Oncology
Open access |
Oct 2020 |
1,243 |
| 49 |
Ustekinumab as Induction and Maintenance Therapy for Ulcerative Colitis
Bruce E. Sands, William J. Sandborn, Remo Panaccione et al. · New England Journal of Medicine
Open access |
25 Sep 2019 |
1,219 |
| 50 |
European Federation of Neurological Societies/Peripheral Nerve Society Guideline on management of chronic inflammatory demyelinating polyradiculoneuropathy: Report of a joint task force of the European Federation of Neurological Societies and the Peripheral Nerve Society — First Revision
Peter Y. K. Van den Bergh, Robert D. M. Hadden, P. Bouché et al. · European Journal of Neurology
|
23 Feb 2010 |
1,140 |